Merck Sharp & Dohme LLC patent applications published on July 25th, 2024
Contents
- 1 Patent applications for Merck Sharp & Dohme LLC on July 25th, 2024
- 1.1 ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS (18557667)
- 1.2 IL4I1 INHIBITORS AND METHODS OF USE (18556196)
- 1.3 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT (18557458)
- 1.4 ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS (18630437)
- 1.5 METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST (18561331)
- 1.6 TRANSAMINASE ENZYMES FOR THE TRANSAMINATION OF (1S,5R)-6,8-DIOXABICYCLO[3.2.1]OCTAN-4-ONE ([[Merck Sharp & Dohme LLC (18563157). TRANSAMINASE ENZYMES FOR THE TRANSAMINATION OF (1S,5R)-6,8-DIOXABICYCLO[3.2.1]OCTAN-4-ONE simplified abstract|18563157]])
Patent applications for Merck Sharp & Dohme LLC on July 25th, 2024
ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS (18557667)
Main Inventor
Ashok Arasappan
IL4I1 INHIBITORS AND METHODS OF USE (18556196)
Main Inventor
George Madalin GIAMBASU
SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT (18557458)
Main Inventor
Kazuaki SHIBATA
ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS (18630437)
Main Inventor
Kalpit A. Vora
METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST (18561331)
Main Inventor
Razvan CRISTESCU
TRANSAMINASE ENZYMES FOR THE TRANSAMINATION OF (1S,5R)-6,8-DIOXABICYCLO[3.2.1]OCTAN-4-ONE ([[Merck Sharp & Dohme LLC (18563157). TRANSAMINASE ENZYMES FOR THE TRANSAMINATION OF (1S,5R)-6,8-DIOXABICYCLO[3.2.1]OCTAN-4-ONE simplified abstract|18563157]])
Main Inventor
Karla M. Camacho Soto
